Novartis' blockbuster immunology drug Cosentyx has disappointed in a phase 3 trial involving patients with giant cell arteritis (GCA), a debilitating autoimmune disease affecting the arteries. In the ...
Billionaires are using their money to buy politicians, control governments, and shape the news. Together, we can reclaim our power and build a more equal future. Every signature unlocks $1 to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results